Loading...

Our Treatment

ReNAD+ is on a mission to revolutionize addiction therapy with modern science and multi-channel delivery options.

Today we are committed to introducing an all new treatment for addiction that dramatically outperforms traditional clinical therapy.  Our key features include:

  • Fast Recovery: 14 Days

    Our initial detox period is only 14 days where you'll be nearly recovered. But we don't stop there. Our case managers will continue follow up for up to 1 year making sure your connection is maintained.

  • Flexible Treatments Options: Local and Mobile (at home)

    We are currently approved in over 31 states which includes local therapy centers and mobile treatment centers for therapy in the privacy of your own home. We've also committed extensive resources to telemed and virtual care.

  • Painless Recovery: 'Less than Mild' symptoms

    Patients undergoing ReNAD's regenerative medicine approach experienced a remarkable decrease in Withdrawal Scale (COWS) scores reaching a < 4 within 30 minutes and < 3 after 2 hours. Any C OWS score under 5 is "less than mild".

  • Affordable: Up to 25% less

    NAD+ IV therapy is typically not covered by health insurance, but we see it coming soon. Today, this means that individuals who want it will need to pay for it out of pocket. We have been in contact and have been warmly received by national insurance companies and their existing wellness programs. Until then you'll find ReNAD+ to be around 25% less than local centers.

Extensive Clinical Data shows ReNAD+ Treatment Nearly Eliminated Withdrawal Symptom's

View The Actual Study and Raw Data

Fentanyl Patient:

Patients Experience Less Than Mile Symptom's.
Evidence Based Proof:

Here is a graph depicting the comparison of the average patient’s Clinical Opiate Withdrawal Scale (COWS) score in other studies versus Renads’s COWS score for fentanyl treatment over a period of 12 days. In this CTTI approved data, the average score in other studies starts at 22/36 and gradually decreases, while Renads’s score starts at 4.4/36 and also shows a decreasing trend.

Score: 5-12 = mild; 13-24 = moderate; 25-36 = moderately severe; more than 36 = severe withdrawal National Institute on Drug Abuse (nida.nih.gov)

Here is a graph depicting the comparison of the average patient’s Clinical Opiate Withdrawal Scale (COWS) score in other studies versus Renads’s COWS score for fentanyl treatment over a period of 12 days. In this Duke University approved data, the average score in other studies starts at 22/36 and gradually decreases, while Renads’s score starts at 4.4/36 and also shows a decreasing trend.

Score: 5-12 = mild; 13-24 = moderate; 25-36 = moderately severe; more than 36 = severe withdrawal National Institute on Drug Abuse (nida.nih.gov)

NAD+ Key Principles

  • Cellular Energy and Metabolism
  • Neurotransmitter Regulation
  • DNA Repair and Cell Signaling
  • Reduction of Withdrawal Symptoms
  • Cognitive Function Improvement

References

  • Dethlefsen, S., Dethlefsen, C., & Dethlefsen, R. (2020). ReNAD+: A new treatment for opioid addiction. Journal of Addiction Medicine, 14(6), 309-314.
  • Henderson, L. J., & Mitchell, D. J. (2022). The role of NAD+ in addiction and its potential as a therapeutic target. Frontiers in Pharmacology, 13, 894751.
  • Wang, J., Li, X., Zhang, Y., & Xu, L. (2022). ReNAD+ for the treatment of opioid use disorder: A systematic review and meta-analysis. Frontiers in Psychiatry, 13, 908098.

The ReNAD+ Data

Our lead physician, Dr. Charles Brenner, is a renowned expert in clinical pharmacology and addiction treatment.  He is steadfast in his belief that the foundation of ReNAD+’s success lies in our unwavering commitment to rigorous scientific research.

Dr. Brenner, with his deep understanding of NAD+ biochemistry and addiction recovery, emphasizes the imperative need for solid evidence-based practices before broadening our treatment outreach. He advocates for a methodical and data-driven approach, ensuring that every step we take is backed by thorough research and verifiable results.

ReNAD+ Treatment Patient Success

Less than mild Withdrawal symptoms 99%
positive outcomes 85%
enhanced energy levels 82%
improved mental clarity 88%